Industry Focus

Bristol-Myers Squibb's Opdivo came up short in a key lung cancer trial, causing shares to plummet. Should investors panic?

Direct download: 08102016_IF_Healthcare.mp3
Category:Podcast -- posted at: 3:30pm EDT